SCHEMBL17822274

SCHEMBL17822274

CCS[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](OCc2ccc3ccccc3c2)[C@H]1OCc1ccc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 6/20 0.52
SSTR5 P35346 3/20 0.46
SSTR1 P30872 2/20 0.46
SSTR2 P30874 2/20 0.46
SSTR3 P32745 2/20 0.46
NT5E P21589 1/20 0.46
TACR2 P21452 3/20 0.41
LGALS9 O00182 1/20 0.40
LGALS8 O00214 1/20 0.40
LGALS1 P09382 1/20 0.40
LGALS3 P17931 1/20 0.40
LGALS7; LGALS7B P47929 1/20 0.40
PTPN1 P18031 4/20 0.40
REN P00797 1/20 0.39
GJA1 P17302 1/20 0.39
GJB2 P29033 1/20 0.39
PTPN2 P17706 1/20 0.38
PTPN11 Q06124 1/20 0.38
CDC25B P30305 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17822275 1.00 SSTR4 (0.52) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL23319661 0.97 SSTR4 (0.52) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL14672596 0.89 SSTR4 (0.53) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL13402468 0.88 NT5E (0.55) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL9210267 0.88 NT5E (0.55) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL13857154 0.88 NT5E (0.55) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL24107980 0.85 SSTR4 (0.51) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL23603474 0.85 NT5E (0.52) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL17822287 0.85 SSTR4 (0.61) SSTR4SSTR5SSTR1SSTR2SSTR3
SCHEMBL23319660 0.84 SSTR4 (0.52) SSTR4SSTR5SSTR1SSTR2SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10188718-B2 Vaccines against Streptococcus pneumoniae serotype 4 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2019-01-29 US disclosed
EP-3230297-B1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 MAX PLANCK GESELLSCHAFT (DE) 2018-10-17 EP disclosed
US-20170333545-A1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2017-11-23 US disclosed
EP-3230297-A1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2017-10-18 EP disclosed
WO-2016091399-A1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333545-A1 VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 NEU4, PA2G4, STT3B SSTR4 420/4885SSTR5 1328/4885SSTR1 2461/4885
US-10188718-B2 Vaccines against Streptococcus pneumoniae serotype 4 NEU4, PA2G4, STT3B SSTR4 420/4885SSTR5 1328/4885SSTR1 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.